News
Bottom Line: If you’re serious about burning more fat, feeling energized, and taking control of your body composition, PhenQ ...
SYNC isn’t just about losing a few pounds. It’s about helping your body function better, every day. Chromium helps balance ...
Orion Corporation (“Orion”) and Criceto IKM B.V. (“Criceto”) today announced the signing of an exclusive license agreement for the development and commercialization of APORON®, a novel apomorphine ...
Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in Q1 2024. Sales volume in the ...
“No one should have to wait days—or weeks—for approval to receive needed care,” said Ganesh Padmanabhan, CEO of Autonomize AI ...
Vitamin D is another crucial component that boosts the immune system and prevents the development of insulin resistance. It ...
Author Andrew Leland Breaks Down Misconceptions of People with Disabilities; Business Leader Thomas Wlodkowski Recognized for Bolstering Access to Media; Mattel Lauded for Blind Barbie’s Global Impact ...
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32%1 ...
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today ...
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...
FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced the publication of a groundbreaking paper in the journal Science Advances detailing the ...
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results